(Q43975017)

28 November 2017

Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure (English)

1 reference

28 November 2017

1 reference

Kou Gi Shyu

1

1 reference

28 November 2017

Jun Jack Cheng

series ordinal

2

1 reference

28 November 2017

Peiliang Kuan

series ordinal

3

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Journal of the American College of Cardiology

28 November 2017

1 reference

28 November 2017

40

1 reference

28 November 2017

8

1 reference

28 November 2017

1383-1388

1 reference

Contrast nephropathy after coronary angioplasty in chronic renal insufficiency

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Renal implications of percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Risks for renal dysfunction with cardiac angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Dosing of contrast material to prevent contrast nephropathy in patients with renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Risk of radiocontrast nephropathy in patients with and without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Use of dopamine in prevention of contrast induced acute renal failure--a randomised study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Hypoxia of the renal medulla--its implications for disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

N-acetyl-L-cysteine for preventing lung reperfusion injury after liver ischemia-reperfusion: a possible dual protective mechanism in a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902308-2

7 January 2021

10.1016/S0735-1097(02)02308-2

Identifiers

DOI

1 reference

28 November 2017

1 reference